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Executive Summary
The Government of India has committed to increasing modern contraceptive use from 47.7 percent (IIPS
and ICF 2017) to 54.3 percent among married women aged 15-49 by 2020 (FP2020 and Government of India
2017). To achieve this goal, India has committed to increase access, choice, and quality of family planning
(FP) services by focusing on modern reversible methods. Among married women using a modern
contraceptive method, 75 percent use female sterilization, 12 percent use condoms, 9 percent use oral
contraceptive pills, 3 percent use IUDs, one percent use male sterilization, and 0.4 percent use injectables
(IIPS and ICF 2017). Discontinuation rates for modern reversible methods are high, with 44 percent of
episodes of modern reversible method use discontinued within the first year (IIPS and ICF 2017).
To better understand the dynamics of reversible modern contraceptive use in India, The Evidence Project,
led by the Population Council with support from the United States Agency for International Development
(USAID)/India, conducted a prospective cohort study of married women in India who initiated a reversible
modern contraceptive method. The objectives of the study were to:






Explore one-year contraceptive use dynamics among a cohort of modern reversible contraceptive
users by modern method (oral contraceptive pill, IUD, injectable).
Understand the reasons for discontinuation of modern reversible contraceptive methods.
Examine the experience of side effects of modern reversible contraceptive users.
Assess the quality of care received by clients at time of method adoption.
Understand experiences using and obtaining contraceptive methods over the course of 12 months.

The study enrolled a cohort of 2,699 married women aged 15-49 who initiated a new episode of using a
reversible contraceptive method: postpartum intrauterine device (PPIUD), interval IUD, injectable
contraceptive, or oral contraceptive pill (OCP). New episodes of use included women who had never used a
method before and those that had previously used a method but were not using at the time of study
enrollment. Women were interviewed in-person at four time points: within one month of initiating the
method (enrollment), and 3, 6, and 12 months later. The study was conducted in Haryana and Odisha states,
and women were enrolled primarily at government and non-governmental organization (NGO) facilities and
through accredited social health activists (ASHAs) at the community level. Respondents were purposively
sampled; therefore, proportions are not representative at the state level or representative of method-specific
family planning users. The study was reviewed and approved by the ethics committee of the Government of
Odisha and by the Institutional Review Board of the Population Council. All women enrolled into the study
gave written consent for voluntary participation in the study before enrollment and before all follow-up
interviews.
Of the 2,699 women enrolled into the study, 412 began using the PPIUD at enrollment, 640 began using the
interval IUD, 581 began using the injectable, and 1,066 began using OCPs. At enrollment, 71 percent of the
women were between 20 and 29 years old, 84 percent were Hindu, 51 percent had secondary or higher levels
of education, and 99 percent had at least one child. Fifty-nine percent did not want to have any more children
in the future at the time of the enrollment interview. Fifty-two percent had used a modern method of
contraception in the past. Key findings of the study included:
Across four domains of quality of care (respectful care, information exchange to enable appropriate method
selection, effective use of method selected, and continuity of contraceptive use and care), PPIUD users
consistently reported receiving lower levels of quality of care than users of other methods. At enrollment, 38
percent of OCP users, 38 percent of interval IUD users, 35 percent of injectable users, and 17 percent of
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PPIUD users reported receiving the Method Information Index Plus (MIIplus), meaning they answered “yes”
to four questions: 1) Were you told about other methods, 2) Were you told about potential side effects of the
method you selected, 3) Were you told what to do if you experience side effects/problems with the method
you selected, and 4) Were you told about the possibility of switching methods if the method you selected was
not suitable? Among users of the PPIUD, interval IUD, and OCP, receipt of the MIIplus increased with
wealth tertile.
Implications: Quality of care should be improved for users of all modern methods of family
planning, and especially for PPIUD users and women of lower wealth status. Quality of care
improvement efforts should also be routinely monitored and tracked to ensure that women are
receiving high quality services. Providers of all cadres should be trained on respectful care, and
information exchange on appropriate method selection, effective use of methods, and continuity
of contraceptive use and care.
Over the course of 12 months, 23 percent of women (n=2,559) reported experiencing side effects of their
enrollment method, including 50 percent of injectable users, 22 percent of PPIUD users, 22 percent of
interval IUD users, and 11 percent of OCP users. Eighteen percent of women reported talking to someone
about side effects, and 12 percent talked to their provider/ASHA about the side effects they experienced.
Common side effects experienced were abdominal cramping/pain among PPIUD users (10%) and interval
IUD users (13%); heavy menstruation among PPIUD users (9%) and injectable users (12%); and absence of
menstruation among injectable users (25%).
Among women who discontinued the enrollment method (n=921) at some point during the study, 24 percent
did so because of side effects experienced or health concerns. An additional 20 percent reported not
menstruating since starting the method as the reason why they discontinued the method. Not menstruating
was the most common reason why women who initiated the injectable stopped using the method. Twelve
percent discontinued because they wanted to become pregnant, and 10 percent discontinued because their
husband was not living at home, suggesting these women no longer had a need for family planning.
Implications: Most women (77%) did not report experiencing side effects of their enrollment
method, though many who discontinued the enrollment method did so due to side effects or other
health concerns. Contraceptive initiators should receive follow-up visits from frontline health
workers to provide support and answer questions related to the method selected. These visits
could assist women with information on managing side effects or switching to a different method.
While most women—61 percent—continued to use the method they adopted at enrollment throughout the
year, considerable movement among contraceptive use states was observed, including switching to different
FP methods, continuing use of the switched methods, or discontinuing contraceptive use altogether. Interval
IUD (74%) and OCP (75%) users were most likely to continue to use these methods they began at
enrollment, followed by PPIUD users (66%). Less than half (44%) of injectable users continued to use
injectables. Overall, discontinuation of all contraception was low, at 13 percent. However, half of those not
using any method did not want to have any more children in the future, 7 percent wanted to wait more than
two years, and 12 percent didn’t know. These women, a total of 69 percent of non-users, therefore had an
unmet need for contraception at the end of one year. These findings highlight the importance of providers
and ASHAs offering continuous support to women who want to delay or prevent pregnancy that includes
opportunities to switch methods as their fertility desires change over time. Information and FP methods
offered to women at the initial FP visit alone is not enough to ensure that women continuously meet their
needs for voluntary contraceptive use; continuous follow-up is needed.
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Implications: Discontinuation of contraceptive use altogether after one year was relatively low.
There was considerable movement between various states of contraceptive use. Women did
switch to other methods, both modern as well as traditional methods. Among those who were not
using at 12 months, however, the majority had an unmet need for family planning. At the time of
method adoption and after the initial visit, it is important to continue to offer women information
about the possibility of switching to other methods, including modern fertility awareness-based
methods.
At enrollment, most women wanted to use their family planning method for limiting (59%) or delaying
childbearing for at least two years (28%). While these preferences appeared to be relatively stable over time,
there were substantial variations in fertility preferences over the course of the study at the individual level. For
example, when examining the data longitudinally, over one-third (35%) of women who did not want to have
any children at enrollment changed their mind and reported wanting to have more children in at least one
follow-up interview. Additionally, a significant proportion didn’t know whether or when they wanted to have
another child in at least one interview, as 6 percent of respondents at enrollment and 15 percent after one
year were unsure. Being unsure of fertility preferences is a legitimate response that may change over time, and
providers and ASHAs should be sure to ask women about their fertility preferences at each interaction. When
asking women about their fertility desires, a better understanding of their motivations to prevent pregnancy
and under what circumstances they may change their mind may help providers support women in selecting
appropriate methods.
Implications: These data show that while fertility intentions appear to remain relatively
consistent over a year, women’s desires can and do change. Asking women about their fertility
intentions and motivation to prevent pregnancy routinely in FP counseling can help ensure that
women are selecting methods that best meet their changing reproductive needs.
After one year, 62 percent of respondents did not want to have any more children. While those using modern
methods after one year were most likely to report not wanting to have any more children (64%), over half of
those using traditional methods (56%) and half of those not using any method (50%) did not want any more
children either. These women would be potential candidates for modern methods of contraception and
should be supported in switching to a different modern method according to their reproductive needs. Since
such a large proportion of modern, traditional, and non-users of family planning desired no more children,
and since this was the strongest fertility preference among this sample of women, there is a rationale to
continue supporting the female sterilization program in India. Coupled with counseling about fertility
preferences and motivation to prevent pregnancy, this could help enable women in India with an unmet need
for FP for limiting births to meet their reproductive intentions.
Implications: India should continue to expand the basket of methods available to women while
supporting sterilization as part of the national family planning program.
Seven percent of women experienced a pregnancy at some point during the study (including women who
were using and not using a contraceptive method at the time they became pregnant). Of the 183 women who
experienced a pregnancy during the study period, half (51%) did not want to become pregnant at all, did not
want to become pregnant at that time, or didn’t know. Less than 10 percent of women who experienced a
pregnancy terminated the pregnancy.
Implications: As half of pregnancies experienced in this study were not wanted at all or at that
time, there is a need to ensure that women are offered an array of methods to switch to in order to
prevent unwanted pregnancies.
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Introduction
Use of modern contraceptive methods in India has steadily increased from 37 percent among married women
aged 15-49 in 1992-93 (IIPS 1995) to 48 percent in 2015-16 (IIPS and ICF 2017). At the London Summit on
Family Planning in 2017, the Government of India articulated a commitment to increase modern
contraceptive use to 54.3 percent among married women of reproductive age by increasing access, choice,
and quality of family planning (FP) services (FP2020 and Government of India 2017). As part of its FP2020
commitment, India aims to expand method choice available to women by focusing on modern reversible
methods, including the intrauterine contraceptive device (IUD) and postpartum IUD (PPIUD).
Currently, the method mix in India is heavily skewed toward female sterilization. It is used by 75 percent of
married women who are using a modern contraceptive method (IIPS and ICF 2017). Other methods used
include condoms (12%), oral contraceptive pills (OCPs) (9%), IUD (3%), male sterilization (1%), and
injectables (0.4%). Discontinuation rates for these reversible methods, however, remain high, as 44 percent of
episodes of use of all modern reversible methods are discontinued within one year (IIPS and ICF 2017). Oneyear discontinuation rates are highest for injectables (51%), followed by condoms (47%), OCPs (42%), and
the IUD (26%). While 12 percent discontinued because they wanted to have a child, only in 6 percent of
discontinued episodes did the woman switch to a different FP method (IIPS and ICF 2017), suggesting that
most women who discontinue may continue to have a need for family planning.
To enable India to meet its FP2020 goals and design programs that meet the needs of women and their
families, a better understanding of contraceptive use dynamics, including contraceptive choice,
discontinuation, and switching behaviors, is paramount. To fill this gap in the literature, The Evidence
Project, led by the Population Council and funded by the United States Agency for International
Development (USAID)/India, conducted a prospective cohort study of married women in India who
initiated a reversible contraceptive method. Most research to date on contraceptive use dynamics has been on
contraceptive use retrospectively. For example, the Demographic and Health Surveys (DHS) ask women to
recall all episodes of contraceptive use and reasons for discontinuing those episodes in the 3-59 months prior
to the interview (IIPS and ICF 2017). Asking women their reasons for discontinuing a method that may have
occurred five years ago introduces the possibility of recall bias. The present study, on the other hand, was
conducted prospectively over the course of one year, reducing the potential for recall bias. Additionally, this
study has focused on less understood aspects of contraceptive use dynamics, including the experience of side
effects and their effect on daily life, quality of care received by clients at the time of method adoption, and
factors that enable method switching among modern contraceptive methods if the current method is not
suitable.
This report summarizes the results of the prospective cohort study on the dynamics of reversible method use.
The findings can be used to inform India’s national family planning program as the government focuses on
increasing access, choice, and quality of FP services with an emphasis on reversible methods.
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Objectives
The objectives of this report are to:






Explore one-year contraceptive use dynamics among a cohort of modern reversible contraceptive
users by modern method (oral contraceptive pill, IUD, injectable).
Understand the reasons for discontinuation of modern reversible contraceptive methods.
Examine the experience of side effects of modern reversible contraceptive users.
Assess the quality of care received by clients at time of method adoption.
Understand experiences using and obtaining contraceptive methods over the course of 12 months.
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Methods
Study design, enrollment, and sampling
A cohort of 2,699 married women aged 15-49 who initiated a
new episode of using a reversible contraceptive method:
postpartum intrauterine device (PPIUD), interval IUD,
injectable contraceptive, or oral contraceptive pill (OCP), was
followed for one year. A new episode of use included women
who had never used a modern method of family planning
previously as well as those who had used a modern method at
some point in the past but had not been using a modern
method just prior to study enrollment.

FIGURE 1. STUDY IMPLEMENTATION
SITES

Women enrolled in the study were interviewed at four time
points: within one month of initiating the method
(enrollment), and 3, 6, and 12 months later. The study was
conducted in nine districts of two Indian states (Figure 1)—
Nuh, Panipat, Rewari, and Sonipat districts of Haryana and
Baleswar, Bhadrak, Kendujhar, Khorda, and Mayurbhanj
districts of Odisha. Women were enrolled from December
2016 to October 2017.
In Haryana, women were enrolled through accredited social
health activists (ASHAs) at the community level. Districts in
which a private organization was implementing an injectable program and where health management
information systems reported a high number of IUDs inserted in the last year were selected for inclusion in
the study, as there was a higher likelihood of identifying modern reversible method users. ASHAs in these
districts identified women who adopted a modern reversible method within the preceding month and asked
their permission to bring a member of the research team to their home. In Odisha, PPIUD users were
primarily enrolled at select government health facilities from delivery wards, though some were enrolled via
ASHAs identified by the facilities. Interval IUD and OCP users were enrolled primarily through ASHAs
identified by facility managers, and injectable users were enrolled primarily at non-governmental organization
(NGO) facilities. Women in this study were sampled purposively. Proportions presented in this report are
limited to the sampled population only and are not to be interpreted as representative of method-specific
family planning users. In addition, while combined results are presented for all women surveyed in this study,
estimates are not representative at the state or district levels.
All interviews were conducted in-person. In both states, women enrolled at facilities were interviewed at the
facility upon being approached by the research team and providing informed consent. Women who were
enrolled through ASHAs gave their consent to the ASHA to be contacted by the research team. The research
team then contacted the women to determine a location for the interview, either at home or at the facility, per
the respondent’s preference. Follow-up interviews were also conducted in-person, either at home or at the
facility. Women who were not reachable at the 3-month or 6-month interview could reenter the study at a
later interview time. Of 2,699 women interviewed at enrollment, 2,306 were re-interviewed 3 months later,
2,396 6 months later, and 2,441 12 months later, resulting in a follow-up rate of 85.4 – 90.4 percent for the
year (Table 1).
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TABLE 1. PROPORTION OF ENROLLED R ESPONDENTS INTERVIEWED AT EACH
TIME-POINT, BY ENROLLMENT METHOD

PPIUD
Interval IUD
Injectable
OCP
Combined

Enrollment
n
412
640
581
1,066
2,699

Month 3
n
%
327
79.4
545
85.2
455
78.3
979
91.8
2,306
85.4

Month 6
n
%
344
83.5
556
86.9
495
85.2
1,001
93.9
2,396
88.8

Month 12
n
%
358
86.9
564
88.1
510
87.8
1,009
94.7
2,441
90.4

Data collection
Data collector training
One study coordinator and five female data collectors were hired in each state. Study coordinators managed
all data collection activities, and female data collectors enrolled all participants and conducted all interviews.
Study coordinators were trained in New Delhi on the study objectives, study instruments, and data collection
using a computer-assisted personal interviewing (CAPI) package. Intensive, one-week trainings of data
collectors were conducted in each state by the research team and respective study coordinator. Trainings
covered the study objectives and purpose, a review of each question and its purpose, a review of informed
consent forms, use of data collection software and CAPI package, and data management including data flow
and file backup. The training also specifically focused on the ethical aspects of the study, including the
meaning and process of informed consent, the importance of protecting the privacy of respondents, and
confidentiality of the information obtained from respondents. Three-day trainings were conducted prior to
each follow-up interview to refresh data collectors’ knowledge and orient them to the new questionnaires.

Data collection
Female data collectors interviewed respondents face-to-face at four time points using mini-laptops. The CAPI
package was developed in Hindi and Odia, the local languages of Haryana and Odisha. Informed consent was
obtained prior to the enrollment interview and each of the three follow-up interviews.
At enrollment, data collectors asked respondents about a range of information including demographic data,
fertility intentions, previous contraceptive use, birth history, counseling received at the time of method
initiation, satisfaction with this visit, contact with frontline health workers, knowledge of contraceptive
methods, reproductive autonomy, household decision making, empowerment, attitudes toward domestic
violence, and couple’s communication about sex. At follow-up interviews, respondents provided information
on changes in family structure and employment, fertility intentions, current contraceptive use, experiences
and management of side effects (if experienced), experiences obtaining OCP and injectable doses, and followup services for IUD. For those who discontinued, additional questions were asked about reasons for
discontinuation, whom the respondents spoke to about the desire to discontinue, counseling received for
respondents who switched to a new method, and, for those who did not switch to a new method, their
intention to use a contraceptive in the future.

Data management and analysis
Data collection supervisors collated the data and sent it to the research team in New Delhi, India, where the
data were carefully reviewed for errors. The research team routinely checked for inconsistencies and cleaned
the data when possible throughout the study period. Respondents were given unique identifiers to enable
them to be linked for follow-up interviews, and these unique identifiers were known only to the research

T H E EV ID EN C E PR OJ E C T | 7

team and stored in a password-protected computer. The text responses for “others (specify)” were examined
and recoded.
Descriptive statistics and bivariate analyses by enrollment method were conducted. Data analysis was
conducted by enrollment method because strategies for enrollment were different for each method. Chisquare tests were used to determine significant differences in experiencing pregnancy by enrollment method
and in receiving the MIIplus (Method Information Index Plus) by respondent characteristics.

Ethical review
The study was reviewed and approved by the ethics committee of the Government of Odisha and by the
Institutional Review Board of Population Council. All respondents gave written consent for voluntary
participation in the study before the enrollment interview and before each of the three follow-up interviews.
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Results
The results section of this report presents an overview of the characteristics of the women enrolled in the
study, their experiences with the enrollment method, including quality of care at the time of method
adoption, experiences of side effects, and reasons for discontinuation of the enrollment method. The report
then presents women’s contraceptive use dynamics after one year, including changes in contraceptive use,
fertility preferences, experiences using and obtaining contraceptive methods, and experiences of pregnancy
during the 12-month period.

Respondent characteristics
Table 2 shows the demographic characteristics of respondents at enrollment by method initiated. Most
women enrolled into the study were between 20 and 29 years old (71%) and Hindu (84%). Overall, 38
percent of the women belonged to marginalized communities, i.e., scheduled castes and scheduled tribes.
Twenty-three percent of women had never attended school, while just over half (51%) had secondary levels
of education or higher. Most were housewives (94%), though a small proportion were manual laborers (2%),
worked in white collar jobs (1.9%), or were farmers (1.5%).
Forty-one percent of women had one child at the time of enrollment while one-third (33%) had two children
and one-quarter (25%) had three or more. Less than one percent did not have any living children (0.7%). At
enrollment, three in five women (59%) did not want to have any more children in the future, 6 percent
wanted to have a child within two years, and just over one-quarter (28%) wanted to have a child in more than
two years. Seven percent didn’t know or were undecided about when they wanted to have a child. Over half
of the women had used a modern method of contraception in the past (52%). Twelve percent had used only
traditional methods 1 previously, while over one-third (36%) had previously never used a contraceptive
method.
Nearly half of respondents (49%) had obtained their current method from public health facilities, while 33
percent obtained it from a frontline health worker, 13 percent from an NGO, 3 percent from a medical store,
and 3 percent from a private facility. Public health facilities include district hospitals, community health
centers, primary health centers, and sub-centers. Frontline health workers include accredited social health
activists (ASHAs), Anganwadi workers (AWW), and auxiliary nurse midwives (ANM). ANMs are permitted
to insert IUDs in India and are based at primary health centers and sub-centers (Scott et al. 2014). Thus, while
some PPIUD and IUD users received their IUD from an ANM, they are counted as receiving their IUD
from a public health facility, as the IUD is not provided via community-based distribution. Additionally, while
11 percent of injectable users and 2 percent of OCP users obtained their injection from a medical store, they
received counseling and a referral for their method from a provider or frontline health worker. NGO facilities
are distinguished from commercial private facilities as they are within the non-profit sector.

1

Traditional methods include withdrawal, abstinence, and rhythm method.
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TABLE 2. RESPONDENT CHARACTERISTICS BY ENROLLMENT METHOD (N=2,699)

Background characteristics
Age group in years
Below 20 years
20-24 years
25-29 years
30-34 years
35 years and above
Religion
Hindu
Muslim
Other
Caste/tribe
Scheduled caste
Scheduled tribe
Other backward class
General
Other
Education
No education
Primary
Middle
Secondary
Higher secondary
Above higher secondary
Employment
Housewife
Business
Farmer
Manual labor
White collar jobs
Parity^
No children
1 child
2 children
3+ children
Fertility preferences
Did not want any more children
Desired within the next year
Desired within 1 to 2 years
Desired after more than 2 years
Did not know when
Previous contraceptive use
Modern method
Traditional methods only
No previous contraceptive use
Current method source
Public health facility
Frontline health worker
Medical store
Private facility
NGO

PPIUD
(n=412)

OCP
(n=1,066)

Combined
(n=2,699)

5.6
58.5
27.7
7.3
1.0

8.4
41.1
30.8
13.3
6.4

0.7
20.3
36.7
22.0
20.3

1.3
32.7
38.6
18.0
9.4

3.5
36.0
34.6
16.1
9.7

97.3
1.9
0.7

92.5
7.2
0.3

67.5
32.2
0.3

83.2
16.6
0.2

84.2
15.5
0.3

15.5
33.7
19.4
30.3
1.0

13.8
31.7
28.4
23.0
3.1

13.4
5.7
30.1
41.1
9.6

23.4
16.0
29.1
29.0
2.6

17.7
20.2
27.7
30.4
4.0

16.8
16.0
16.3
35.9
9.5
5.6

23.6
9.2
13.3
25.2
17.3
11.4

30.3
10.5
13.1
24.6
9.6
11.9

20.9
12.7
14.8
32.8
11.3
7.5

22.9
11.9
14.3
29.7
12.1
9.1

92.2
0.5
1.5
4.9
1.0

91.9
0.6
4.8
1.1
1.6

93.6
0.7
0.2
2.4
3.1

95.4
0.8
0.3
1.6
1.9

93.7
0.7
1.5
2.1
1.9

0.7
59.7
31.1
8.3

0.3
38.9
36.9
23.7

0.3
25.5
38.4
35.8

1.1
44.6
28.6
25.7

0.7
41.4
33.0
24.7

43.7
0.0
2.7
49.3
4.4

61.6
1.3
3.3
26.9
7.0

78.0
0.5
5.9
12.1
3.6

53.0
1.8
7.5
28.7
9.0

59.0
1.1
5.4
27.8
6.7

31.1
11.4
57.5

49.5
13.9
36.6

64.0
9.0
27.0

55.6
11.3
33.1

52.2
11.5
36.3

100
0.0
0.0
0.0
0.0

90.5
0.0
0.0
6.3
3.3

37.4
1.7
11.4
3.8
45.8

10.5
82.0
1.3
0.8
5.4

48.9
32.8
3.0
2.6
12.8

^Percentages may not add to 100% due to missing values
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Enrollment Method
Interval IUD
Injectable
(n=640)
(n=581)

Quality of care received at enrollment
At enrollment into the study, all women were asked about the quality of care they received during their visit
with a provider or a frontline health worker to obtain their family planning method. Though 3 percent
obtained their method (injectable or OCP) from a medical store, the counseling for the method was done by
a provider at a public facility or by a frontline health worker. This study did not observe providers during the
family planning counseling interactions, but rather captured the care and information received as reported by
clients after the interaction. Clients were interviewed within one month of receiving their enrollment method,
in efforts to minimize recall bias.
Measures of quality were broken down into four domains of process quality (Jain, Townsend & Ramarao
2018; Jain et al. 2019a):
1) Respectful care relates to interpersonal interactions between provider and client and assesses
aspects of privacy and confidentiality.
2) Method selection focuses on exchange of information between a provider and client to enable
selection of an appropriate method.
3) Effective use of the selected method includes information given to the client about the selected
method.
4) Continuity of contraceptive use and care covers information on follow-up appointments and the
ability to switch methods or sources of family planning.
Figure 2 presents aspects of respectful care received by women when they initiated the enrollment method.
Nearly all women reported they were treated well by the provider (99-100%), regardless of method received.
For other indicators, a greater proportion of injectable and OCP users reported receiving respectful care
compared to interval IUD and PPIUD users. For example, 97 and 99 percent of OCP and injectable users,
respectively, reported that their questions were answered to their satisfaction, while this was reported by 86
percent of interval IUD and 70 percent of PPIUD users. Eighty-two percent of injectable and OCP users felt
they had visual privacy during their counseling session, compared to 68 percent of IUD and 53 percent of
PPIUD users.
FIGURE 2. RESP ECTFUL CARE AT INITIAL VISIT BY ENROLLMENT METHOD
99 99 99100

Treated well by provider
70

Questions answered to satisfaction

86

59

Allowed to ask questions

80

56

92 92

78 80 86

60

Felt information will be kept
confidential

97 99

70

85 87

Felt audio privacy
Felt visual privacy
PPIUD (n=412)

53
0
Interval IUD (n=640)

25

50
Percent
Injectables (n=581)

68

82

82

75

100

OCP (n=1,066)
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Figure 3 presents women’s reporting of information received and questions asked by the provider that would
enable appropriate method selection. Fewer PPIUD users reported being asked about or receiving
information for method selection compared to interval IUD, injectable, or OCP users. Eighty-six percent of
OCP and injectable users and 73 percent of interval IUD users reported being asked about their preferred FP
method compared to only 31 percent of PPIUD users. Less than half of all users received information about
methods that protect against STIs or HIV (10% of PPIUD users, 40% of injectable and OCP users, and 47%
of interval IUD users) or received information without any one method being promoted (29% of PPIUD and
OCP users, 32% of interval IUD users, and 38% of injectable users).
FIGURE 3. METHOD SELECTION AT INITIAL VISIT BY ENROLLMENT METHOD
31

Asked preferred FP method

35

Told about other methods

Received information about methods
that protect against STIs/HIV
Received information without any
method being promoted
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70 72

40 40 47
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0
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25

50
Percent
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75
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100

Women were asked about the information that they were given about effective use of the method that they
selected at enrollment (Figure 4). While only 53 percent of PPIUD users were told how to use the selected
method, 85 percent of IUD, 92 percent of injectable, and 97 percent of OCP users reported receiving this
information. Most women reported that they were told how their chosen method works: 66 percent of
PPIUD users, 67 percent of injectable users, 79 percent of IUD users, and 91 percent of OCP users. Fewer
women, however, reported that they were told about method-related side effects (27% of PPIUD, 47% of
interval IUD, 48% of OCP, and 58% of injectable users), how to manage side effects/problems (25% of
PPIUD, 44% of OCP, 45% of interval IUD, and 45% of injectable users), and the warning signs (severe
adverse effects) associated with the method selected (27% of PPIUD, 33% of OCP, 43% of injectable, and
45% of interval IUD users).
FIGURE 4. EFFECTIVE USE OF SELECTED METHOD AT INITIAL VISIT BY
ENROLLMENT METHO D
53

Told how to use selected method

85

66 67

Told how chosen method works
Told side effects of selected method
Told how to manage side effects/
problems
Told warning signs associated with
method
0
PPIUD (n=412)

Interval IUD (n=640)

27

91
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25
27 33
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47 48
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43 45
50
Percent

Injectables (n=581)

75

100
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T H E EV ID EN C E PR OJ E C T | 1 3

Figure 5 presents the final domain of quality of care: clients’ reports of information given to enable continuity
of contraceptive use and care. More PPIUD (74%), interval IUD (81%), and injectable users (81%) were told
about the timing of their next visit compared to OCP users (47%). Being told about the possibility of
switching methods if current method was not suitable ranged from a low of 41 percent among PPIUD users
to 71 percent of interval IUD users. The percentage of women who were told about other sources of
contraceptive supply ranged from 41 percent of PPIUD users to 70 percent of OCP users. Seventy-five
percent of injectable users, 50 percent of interval IUD users, and 36 percent of PPIUD users were given an
appointment card for their next visit. Few OCP users (9%) were given an appointment card.
FIGURE 5. CONTINUITY OF CONTRACEPTIVE USE AND CARE AT INITIAL VISIT BY
ENROLLMENT METHO D
47

Told about timing of next visit
Told about possibility of switching
the method if selected method was
not suitable

41

Given appointment card for follow-up
visit
0
PPIUD (n=412)
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Method Information Index Plus (MIIplus)
The Method Information Index (MII) is a core indicator that FP2020 uses to track progress towards
achieving 120 million additional users of contraceptives by 2020. It is an indicator of informed choice and
consists of three questions: 1) Were you told about other methods, 2) Were you told about potential side
effects of the method you selected, and 3) Were you told what to do if you experience side effects? Women
who answered “yes” to all three are considered to have received full information of the MII.
As shown elsewhere using data from this study (Jain et al. 2019b), adding a fourth question to the MII about
the possibility of switching methods if the method selected was no longer suitable better predicts
contraceptive continuation three months later. This new measure, the MIIplus, is calculated as the percentage
of women who answer “yes” to all four questions. Overall, few women reported receiving all four
components of the MIIplus. Among PPIUD users, 17 percent reported receiving MIIplus. More than onethird of injectable (35%), interval IUD (38%), and OCP (38%) users reported receiving all four components
of the MIIplus (data not shown).
Figure 6 presents women’s receipt of the MIIplus by women’s characteristics of age, parity, education, and
previous modern method use. There were no significant differences by age of women in reported receipt of
the MIIplus for users of any method. Reported receipt of the MIIplus varied by education level for PPIUD
and OCP users. PPIUD users and OCP users who had secondary or higher levels of education were more
likely to report receiving complete MIIplus. In addition, there was a significant difference in women who
reporting receiving MIIplus by parity for interval IUD and OCP users. Among interval IUD users, receipt of
MIIplus was lowest for those with none or one child, at 33 percent, compared to 43 percent among those
with three or more children. OCP users with two children were least likely to report receiving MIIplus, at 32
percent, compared to 43 percent of those with at least three children. Previous modern method use
influenced the MIIplus information received for interval IUD (46%), injectable (40%), and OCP (49%) users.
Receipt of the MIIplus was significantly different by wealth tertile for users of PPIUD (5% of those in the
lowest tertile compared to 24% in the highest), interval IUD (24% in the lowest tertile compared to 53% in
the highest), and OCP users (20% in the lowest and 59% in the highest). For injectable and OCP users,
receipt of the MIIplus was less likely for those in rural areas (30% of injectable and 36% of OCP) than those
in urban areas (42% of injectable and 49% of OCP users).
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FIGURE 6. RECEIPT O F COMPLETE INFORMATION ON THE MIIPLUS AT
ENROLLMENT, BY METHOD AND RESPONDENT CHARACTERISTI CS
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Experiences of side effects on enrollment method
Women who completed at least one follow-up interview (n=2,559) were asked whether they had experienced
side effects while using the enrollment method. This included women who had continued using the
enrollment method, discontinued it, or switched to a different method at any follow-up interview. Those who
continued using the enrollment method throughout the study were asked about side effects of that method at
each follow-up interview. Women who discontinued were asked about their side effects of the discontinued
enrollment method at the first follow-up interview after discontinuation.
Table 3 presents women’s experiences of side effects. Throughout the 12-month study period, 23 percent of
respondents experienced side effects while using their enrollment method. Half of injectable users (50%)
reported experiencing side effects of the method. Lower proportions of PPIUD (22%) and interval IUD
(22%) users reported experiencing side effects. Eleven percent of OCP users reported experiencing side
effects of the method.
Among all contraceptive users, the three most commonly reported side effects were heavy bleeding (6%),
abdominal pain/cramping (6%), and no bleeding (6%). For method-specific side effects, 25 percent of
injectable users reported no bleeding as a side effect of the method. For PPIUD (10%) and IUD (13%) users,
abdominal pain/cramping was the most common side effect, while weakness and dizziness (4% each) were
the most common for OCP users.
TABLE 3. EXPERIENCES OF SIDE EFFECTS ON ENROLLMENT METHOD, BY
ENROLLMENT METHO D

Experienced side effects on
enrollment method
Side effects experienced†
Heavy bleeding
Abdominal pain/cramping
No bleeding
Weakness
Dizziness
Little bleeding
Backache
Irregular menstruation
Nausea
Headache
Weight gain
Swollen feet
Vomiting
Vaginal discharge
Weight loss
Spotting
Vaginal itch
Breast pain, tenderness, or
swelling
Vaginal inflammation
Fever
High blood pressure
Low blood pressure
Other
Don't know

PPIUD
(n=376)
22.3

Enrollment Method
Interval IUD
Injectable
(n=620)
(n=531)
21.8
49.7

OCP
(n=1,032)
10.8

Combined
(n=2,559)
23.2

8.8
10.4
0.5
4.0
2.1
1.3
1.3
0.3
0.5
0.8
0.0
0.5
0.3
2.9
0.3
0.3
0.8
0.0

4.8
12.6
0.5
2.7
1.9
1.8
4.4
0.7
0.7
0.7
0.0
0.2
0.5
0.8
0.3
0.3
0.7
0.3

12.2
3.0
25.1
4.5
3.8
9.2
2.3
5.8
1.3
1.7
3.8
1.5
0.8
0.2
1.9
1.9
0.8
0.4

1.5
1.0
0.2
3.9
4.2
0.7
0.1
0.5
1.9
1.0
0.5
0.8
1.0
0.1
0.1
0.0
0.0
0.2

5.6
5.6
5.5
3.8
3.2
2.8
1.8
1.6
1.3
1.0
1.0
0.7
0.7
0.7
0.6
0.5
0.4
0.2

0.3
0.0
0.0
0.0
0.5
1.1

0.5
0.2
0.2
0.0
0.7
0.0

0.0
0.6
0.0
0.0
3.4
1.7

0.0
0.0
0.0
0.1
0.5
0.2

0.2
0.2
0.0
0.0
1.1
0.6
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† Multiple

responses possible

On average, across all methods initiated at enrollment, 18 percent of women reported talking to somebody
about side effects experienced (Table 4). Twelve percent reported talking to a provider or ASHA about their
side effects and nearly all of those (11% of total) reported returning to the same provider/ASHA or facility to
discuss side effects. Speaking to a provider or ASHA about side effects varied by method ranging from a high
of 25 percent among injectable users to a low of 6 percent among OCP users.
TABLE 4. REACTIONS TO SIDE EFFECTS OF ENROLLMENT METHOD AMONG
WOMEN WHO EXPERI ENCED SIDE EFFECTS, BY ENROLLMENT METHOD
PPIUD
(n=376)

Enrollment method
Interval IUD
Injectable
(n=620)
(n=531)

OCP
(n=1,032)

Combined
(n=2,559)

Talked to somebody about
experiencing side effects

16.5

17.1

39.2

7.7

17.8

Talked to a provider or ASHA
about side effects

9.8

11.8

24.9

5.9

11.8

Returned to same
provider/ASHA or facility to
discuss side effects

9.6

11.3

22.8

5.5

11.1

Women who experienced side effects were likely to discontinue using their contraceptive method after one
year. Among those who experienced side effects on their enrollment method, only 39 percent of those
interviewed in the 12-month interview (n=576) were still using their enrollment method after one year,
compared to 67 percent of the total sample (data not shown). Twenty-one percent discontinued
contraception altogether, while 25 percent switched to a different modern method and 15 percent switched to
traditional methods (data not shown).
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Reasons for discontinuation of enrollment method
Of the 2,699 women who were enrolled into the study, 5 percent were not interviewed in any of the followup interviews. Because their contraceptive use is not known after the enrollment period, they were excluded
from analyses of enrollment method discontinuation since it is not known if they discontinued the method.
Of the 2,559 who were interviewed in at least one follow-up interview, 921 women (36%) discontinued their
enrollment method at some point during the study duration. This includes women who switched to other
methods at the time of discontinuation or later, and those who discontinued altogether.
Table 5 presents women’s spontaneously reported reasons for discontinuation of the enrollment method
(multiple responses were possible, but responses were not read out). Overall, nearly one-quarter (24%) of
those who discontinued did so due to side effects/health concerns while one-fifth (20%) discontinued the
method because they had not menstruated since starting to use the method. Twelve percent discontinued
because they wanted to become pregnant and 10 percent discontinued because their husband was not living
at home. Nearly one-quarter (24%) did not list a reason for discontinuing their enrollment method.
Reasons for discontinuation varied by method initiated at enrollment. For PPIUD and interval IUD
discontinuers, side effects/health concerns (34% of PPIUD users and 28% of interval IUD users) was the
most common reason for discontinuing. Over half of injectable users who discontinued the method reported
they had not menstruated since beginning the method (51%). OCP discontinuers stopped using the methods
to become pregnant (20%) or because their husband was not living at home (18%).
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TABLE 5. REASONS FOR DISCONTINUATION OF ENROLLMENT METHOD, BY
ENROLLMENT METHO D
Enrollment Method
Discontinuation reason†
Fertility-related reasons
Wants to become pregnant
Husband not living at home
Not having sex
Infrequent sex
Up to god/fatalistic
Can't get pregnant
Menopausal/hysterectomy
Opposition to use
Husband opposed
Mother-in-law opposed
Others opposed
Religious prohibition
Lack of knowledge
Lack of knowledge/does not know any
other method
Knows no source
Method-related reasons
Side effects/health concerns
Not menstruated since start of
method
Lack of access/too far
Costs too much
Inconvenient to use
Interferes with body's normal
processes
Wanted more effective method
Method failure/pregnancy
No reason spontaneously mentioned
†Multiple responses possible
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PPIUD
(n=130)

IUD
(n=168)

Injectable
(n=313)

OCP
(n=310)

Combined
(n=921)

3.8
12.3
3.1
5.4
1.5
3.1
0.0

13.1
7.7
4.8
1.2
1.8
1.8
0.0

5.4
3.5
3.8
1.3
1.0
0.0
0.3

20.3
18.1
1.3
1.6
0.6
0.3
0.0

11.6
10.4
3.0
2.0
1.1
0.9
0.1

13.1
7.7
3.8
0.8

5.4
1.2
0.0
0.0

9.6
3.5
1.0
0.3

3.2
1.6
0.3
0.0

7.2
3.0
1.0
0.2

0.0
0.0

1.8
0.0

0.3
0.3

0.3
0.6

0.5
0.3

33.8

28.0

24.6

17.1

24.0

4.6
0.0
0.0
1.5

4.8
0.0
0.0
5.4

51.4
5.4
1.6
1.9

2.6
1.3
0.0
3.2

19.9
2.3
0.5
2.9

3.8
2.3
0.0
36.2

3.0
4.8
1.8
32.7

6.1
0.3
1.3
13.4

2.3
3.2
3.9
23.2

3.9
2.4
2.1
23.5

Contraceptive use dynamics after 12 months
Table 6 presents a cross-sectional look at methods used at the 12-month follow-up interview by enrollment
method (n=2,441). The percentage of women who were using the enrollment method (highlighted in green)
was the highest for OCP users (75 percent), followed by interval IUD users (74 percent), and PPIUD users
(66 percent). Only 44 percent of injectable users were using the injectable after 12 months.
Across all methods initiated at enrollment, more users switched to a modern method compared to a
traditional method. For example, 23 percent of injectable contraceptive users at enrollment switched to a
different modern method by the 12-month interview compared to 13 percent who switched to a traditional
method (rhythm method, withdrawal, and abstinence; data not shown). Similarly, 16 percent of PPIUD users
switched to another modern method by the 12-month interview while 12 percent switched to a traditional
method. Among interval IUD users, 11 percent switched to another modern method and 5 percent to a
traditional method, while 8 percent of OCP users switched to modern and 3 percent switched to traditional
methods.
PPIUD users at enrollment switched to withdrawal method (9%), condoms (8%), OCPs (5%), and female
sterilization (3%). Interval IUD users at enrollment mainly switched to condoms (4%), OCPs (3%), and
withdrawal (3%). Nearly one-quarter of injectable users at enrollment switched to other methods, such as
OCPs (11%), withdrawal (10%), and condoms (7%). OCP users at enrollment switched to female sterilization
(3%), followed by condoms (2%) and withdrawal (2%).
Compared to other methods initiated at enrollment, injectable users were more likely to discontinue using
contraception altogether by the 12-month interview (20%) while PPIUD users were least likely to discontinue
using contraception by 12-months (6%).
Additional analysis of use dynamics revealed that about five percent of OCP users at enrollment discontinued
the method at some point in the study and then switched back to OCPs by the 12-month follow-up.
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TABLE 6. CONTRACEPTIVE USE AT 12-MO NTH INTERVIEW, BY ENROLLMENT METHO D
Contraceptive method used at 12-month follow-up
Enrollment
method

IUD

Injectable

OCP

Condom

Female
sterilization

Male
sterilization

LAM

Rhythm
method

Withdrawal

Abstinence

Not using
any method

PPIUD
(n=358)

65.6

0.0

5.0

7.8

3.1

0.0

0.0

1.7

8.7

1.7

6.4

Interval IUD
(n=564)

73.8

0.9

3.2

4.4

2.3

0.0

0.0

0.2

2.7

2.1

10.5

Injectable
(n=510)

2.2

43.5

10.8

7.1

2.9

0.2

0.0

0.4

9.8

2.8

20.4

OCP
(n=1,009)

1.4

0.8

75.0

2.2

3.1

0.1

0.3

0.1

1.9

1.3

13.9

Combined
(n=2,441)

27.7

9.6

34.7

4.5

2.9

0.1

0.1

0.4

4.7

1.8

13.4
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Figure 7 is a Sankey diagram showing how individual women moved through various contraceptive use states
over the one-year study period—i.e., at enrollment, and 3, 6, and 12 months later. It includes women who
completed at least one follow-up survey (n=2,559) and excludes 140 women who were lost to follow-up at
the 3-month interview and who never returned to the study. The diagram shows the following contraceptive
use states of women at each time point: consistent use of the enrollment method (continued enrollment
method), use of a different method than the method adopted at enrollment (switched methods), nonuse of
any contraceptive method (discontinued contraception), and lost to follow-up. On the left side of the
diagram, users of each enrollment method are presented by color, and the colors represent the enrollment
method throughout the diagram. For example, women who adopted the PPIUD (n=376) at enrollment are
presented in navy blue and can be followed through the study by this color.
The percentages on the figure represent women’s contraceptive use states cross-sectionally—that is, the
percentage of women at each time point in each state, regardless of their individual movement. At the 3month interview, three-quarters (75%) of women were still using their enrollment methods, and this dropped
slightly to 69 percent at the 6-month interview. By the 12-month interview, over half of women (61%) had
consistently used their enrollment method. Cross sectionally, the percentage of women who switched to a
different method (including both modern and traditional methods), increased from 8 percent at 3 months to
nearly one-quarter (22%) at the 12-month interview. This includes women who switched methods at that
follow-up interview regardless of whether they continued to use the same method at subsequent interview(s).
By the end of the study period, 22 percent of women had switched to a different method. This included 15
percent who switched to a modern method and 7 percent who switched to a traditional method.
Cross-sectionally, the percentage of women who were not using any contraceptive method at each interview
slightly increased from 7 percent at 3 months to 10 percent at 6 months, and to 13 percent at 12 months.
Some women who discontinued a contraceptive method by the 3- and 6-month interview returned to FP by a
subsequent follow-up interview: 3% of women discontinued a method at 3 months and began a new episode
of use at 6 months, and 3% of women were not using a method at 6 months but began a new episode of use
by 12 months. The 13 percent of women who were not using a method at 12-months comprised 4 percent
who wanted a child within the next two years and 9 percent with an unmet need for family planning (data not
shown).2
Figure 7 further demonstrates that although 61 percent of women continued to use the enrollment method
consistently for one year, there is a considerable amount of movement among states: switching to other FP
methods, consistently using the switched methods, or discontinuing contraceptive use altogether. These data
suggest that continuous support of women with information and opportunities to switch methods is critical
to support women’s changing desires for various methods over time. Simply offering and distributing FP
methods at one time is not enough to meet women’s need for voluntary contraceptive use.

Unmet need for family planning includes women who were not using a method but did not want to have any more
children, wanted to wait more than two years, or did not know whether or when they wanted to have a child.

2
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FIGURE 7. WOMEN’S MOVEMENT THROUGH VARIOUS CONTRACEPTIVE U SE
STATES O VER 1-YEAR STUDY PERIOD
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Fertility preferences at 12-month follow-up
Figure 8 presents three pie charts of fertility preferences reported at the 12-month follow-up interview for: 1)
modern method users (n=1,945); 2) traditional method users (n=170); and 3) non-users of any family
planning method (n=326). Most women (64%) who were using a modern method at the 12-month interview
did not want to have any children in the future. Seventeen percent wanted to wait more than two years to
have a child, 3 percent wanted to have a child within one to two years, and one percent wanted to have a
child within the next year. Fifteen percent didn’t know whether or when they wanted to have their next child.
More than half (56%) of traditional method users did not want to have any more children at the time of the
12-month follow-up and 14 percent wanted to wait for two years or more before having their next child. Four
percent wanted a child within one to two years and 2 percent wanted to have a child within the next year.
Nearly one-quarter (24%) didn’t know whether or when they wanted to have their next child. Among women
who were not using any family planning method, 50 percent did not want to have any more children, 7
percent wanted to wait two years or more, and 12 percent didn’t know whether or when they wanted to have
a child, suggesting a significant level of unmet need for family planning among this group of non-users. Over
one-quarter (26%) wanted to have a child within the next year, a much greater proportion than for modern
and traditional method users.
Among the 50 percent of non-users who did not want to have any more children (n=163), the main reasons
for discontinuing their most recent method were not menstruating since beginning the method (reported by
20%), side effects/health concerns (20%), and husband not living at home (18%) (data not shown).
FIGURE 8. FERTI LITY PREFERENCES AT 12-MONTH FOLLOW-UP AMONG USERS OF
MODERN METHODS, TRADITIONAL METHO DS, AND THOSE NOT USING ANY
METHOD
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Figure 9 shows that at the individual-level, fertility preferences change over time and do so within relatively
short time intervals. While looking at the data cross-sectionally, it appears that fertility preferences are
relatively stable—between 54 and 59 percent of respondents reported not wanting any more children at
enrollment. However, when examining preferences at the individual level, preferences can vary substantially
over a one-year period. Among the 59 percent of women who reported not wanting any more children at
enrollment, 35 percent reported they wanted to have a child in at least one follow-up survey (data not shown).
Similarly, while 28 percent of women reported they wanted to wait more than two years before having a child
at enrollment, nearly all (95%) of them changed their preference in a follow-up interview. Among the 6
percent who wanted a child within two years at enrollment, 86 percent changed their preference in at least
one follow-up. Lastly, of the 7 percent of women who were not sure whether or when they wanted a child at
enrollment, 87 percent changed their response in a follow-up interview. Cross-sectionally, the proportion of
women who were unsure whether or when they wanted to have more children doubled by the end of the
study, from 7 percent at enrollment to 15 percent at the 12-month interview.
These data suggest that while cross-sectionally fertility intentions appear to be relatively stable over time,
when examined at an individual level, fertility preferences fluctuate substantially. In these data, 35 percent of
women who had wanted no more children at enrollment changed their fertility preference to wanting a child
at some time-point during the year. This suggests that providers should be cautious about how they use this
measure in supporting women to choose a contraceptive method, especially when counseling on female
sterilization. Understanding the strength of women’s motivations to prevent pregnancy could improve
providers’ counseling and support of appropriate method selection. For example, providers may ask woman
the circumstances that would influence her to change her mind about wanting no more children. Other
changes in fertility preferences were observed to be in an expected direction where over time women moved
from wanting a child in over two years to wanting no more children.
FIGURE 9. INDIVIDUAL WOMEN’S CHANGES IN FERTILITY PREFERENCES OVER 1YEAR STUDY P ERIOD
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Experiences using and obtaining contraceptive methods at 12 months
Experiences with OCP use
Source of OCPs
Women using OCPs at 12-month follow-up (n=848) were asked where they had obtained their most recent
packet of pills (Figure 10). The majority (86%) reported receiving the packet from a frontline health worker,
including ASHAs and AWWs. Eight percent purchased a packet from a medical store, 3 percent received it
from a government hospital, and 2 percent from a private doctor. Eighty-five percent did not pay anything
for their last pill packet, while 7 percent paid between one and 29 rupees, 6 percent paid between 30 and 350
rupees, and 2 percent didn’t know (data not shown). Most women who went to private sources paid for their
pills, as 74 percent of those who went to a medical store paid for their last packet (and an additional 22
percent didn’t know or remember the cost), and 95 percent of those who went to a private doctor paid for
their pill packet. Those who obtained their packet from the public sector were less likely to pay: 10 percent of
those who went to a government health facility and 4 percent who received it from an ASHA paid for their
pill packet (data not shown).
FIGURE 10. SOURCE OF MOST R ECENT OC P PACKET AMONG OC P USERS AT 12MONTH FOLLOW-UP (N=848)
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Missed doses of OCPs
Those using OCPs at 12-months (n=848) were also asked whether they had missed any doses of the pill. 3
Seventeen percent of OCP users reported missing a dose in this period (Table 7). Women were also asked
what they did when they realized they had missed a dose, the reason they missed a dose, and how many times
they had missed a dose. After realizing they had missed the dose, 12 percent of pill users took two pills at
once the next day, and 2 percent took the forgotten pill immediately upon remembering, which are the
correct reactions to a missed dose, while 3 percent took one pill the next day. Less than one percent
discontinued OCPs when they missed a dose. The most common reason reported for missing the dose was
forgetting to take the pill, reported by 10 percent of OCP users, while 4 percent forgot their pill packet while
traveling, 3 percent ran out of pills, and less than one percent reported other reasons. Of those who had
missed a dose, most had missed more than one dose: 8 percent of pill users missed a dose twice and 6 percent
missed a dose three or more times.
TABLE 7. AMONG OC P USERS AT 12-MON THS, THE P ERCENTAGE WHO MISSED A
DOSE AND THEIR REACTIONS, REASONS, AND NUMBER OF DOSES MI SSED
(N=848)
Experiences missing OCP doses
Proportion that missed a dose
Reaction to missed dose
Took two pills at once the next day
Took one pill the next day
Took a pill immediately
Discontinued OCP
Reason the dose was missed
Forgot to take the pill
Forgot pill packet while traveling
Was out of pills
Other
How many times a dose was missed
Once
Twice
Three or more times

OCP users at 12-month (n=848)
%
n
17.0
144
11.6
2.9
2.4
0.1

98
25
20
1

9.6
3.9
3.4
0.1

81
33
29
1

3.2
7.7
6.1

27
65
52

Consistency of OCP use while husband is away
Women whose husbands occasionally lived elsewhere for work (n=265) were asked whether they took their
doses of OCPs when their husbands were away. Seventy-three percent of these women reported that they
took their pills regularly while their husband was away (data not shown).

Experiences with injectable use
Women using the injectable at the 12-month interview (n=235) were asked where they plan to receive their
next dose of the injectable. Just over half (51%) said they would go to a government hospital, 46 percent to
an NGO-run clinic, and 2 percent to a private doctor.

For those who had continued using OCPs since the preceding interview, this question asked about the three months
preceding the interview, while new OCP users since the last interview were asked this since beginning the method.

3
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At their previous visit to receive the injectable method, 48 percent of injectable users at 12 months (n=235)
did not pay for the injectable method, and 46 percent paid 200 rupees for the injection. One percent paid
between 1 and 150 rupees, while 5 percent paid between 300 and 305 rupees (data not shown).

Experiences with IUD use
IUD follow-up visits
The World Health Organization (WHO) recommends women go for a follow up 3-6 weeks after insertion,
and then at any time to discuss side effects, problems, switching methods, or IUD removal (WHO 2016). Of
676 women using the IUD (both PPIUD and interval IUD) at 12-month follow-up interview, just over half
(54%) reported going for a follow-up visit after receiving the IUD and most of them (53%) went to the same
public facility where they had the IUD inserted (Table 8). Of all IUD users, 6 percent went to a follow-up
visit unaccompanied. Twenty-two percent were accompanied by their husband, 22 percent went with an
ASHA, and 2 percent were accompanied by their mother-in-law. Others went to the follow-up visit with their
mother, sister, or someone else. Just over one-quarter (27%) of IUD users went to see if everything was all
right, 20 percent reported that the provider asked them to return, 7 percent went to the facility for child
immunization, and one percent went to consult their provider about side effects.
TABLE 8. PROPORTION OF IUD USERS WHO WENT FOR IUD FOLLOW-UP VISIT,
LOCATION OF VISIT, AND PERSON ACCOMPANIED TO VISIT AMONG IUD USERS AT
12-MONTH INTERVIEW (N=676)
IUD users at 12-month (n=676)
IUD follow-up visits
Proportion that went for follow-up visit
Location of follow-up visit
The same facility as insertion
A different government facility
A different private facility
Person who accompanied IUD user to visit
Husband
ASHA
Mother-in-law
Sister-in-law
Mother
Sister
Other family member or neighbor
No one
Reason for follow-up visit
Just wanted to see if everything was all right
Provider asked respondent to return for follow-up
Went for child immunization
Consult on side effects

%
54.3

n
367

53.0
1.2
0.1

358
8
1

22.3
22.0
1.8
0.7
0.6
0.4
0.3
6.1

151
149
12
5
4
3
2
41

26.5
20.0
6.8
1.0

179
135
46
7

Forty-six percent of IUD users did not go for a follow-up visit after receiving the IUD. Forty-three percent
of IUD users at 12 months said they did not go for a follow-up visit because they did not have any problems
with their IUD. One percent did not have anyone to accompany them to the facility. Other reasons named by
less than one percent of IUD users included not having money to go for a follow-up visit, having personal or
family problems, or feeling afraid to go for a follow-up (data not shown).
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IUD removal
At 12-month follow-up interview, 13 percent of 775 IUD users discontinued using the IUD since the
previous interview. Three percent of IUD users went to the same facility where the IUD was inserted to have
it removed, 4 percent reported going to a different facility from where their IUD was inserted, and 3 percent
reported the IUD was expelled on its own (data not shown).

Experiences with female sterilization
By the 12-month interview, 41 women had transitioned to female sterilization, including 3 percent of those
using PPIUD at enrollment, 2 percent of interval IUD users, 3 percent of injectable users, and 3 percent of
OCP users. Table 9 provides information about their experiences when undergoing sterilization. Forty-four
percent of women reported their sterilization took place in a government hospital; 27 percent in a community
health center, rural hospital, or primary health center; 15 percent went to a government dispensary; and 7
percent went to an NGO or trust hospital.
Sterilization users also reported on the care they received at the time of sterilization. Ninety-five percent said
they were told they would not be able to have any more children before the procedure. Slightly less than half
(46%) reported that the care they received during sterilization was “very good,” 51 percent reported it was
“all right,” and one woman reported it was “not so good.” When asked if they regret having the sterilization,
all women responded that they did not regret having the procedure.
TABLE 9. DETAI LS OF FEMALE STERILIZATION ADOPTION BY 12-MONTH FOLLOWUP INTERVIEW (N=41)
Sterilization users at 12-month
(n=41)
Location of sterilization
Government hospital
CHC/rural hospital/PHC
Government dispensary
NGO or trust hospital/clinic
Private hospital
Other
Respondent was told she would not be able to have additional children
Yes
No
Respondent’s rating of care received during procedure
Very good
All right
Not so good
Respondent regrets having female sterilization
No
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%

n

43.9
26.8
14.6
7.3
2.4
4.9

18
11
6
3
1
2

95.1
4.9

39
2

46.3
51.2
2.4

19
21
1

100

41

Experiences of pregnancy during 12-month study period
At each follow-up interview, women were asked whether they had experienced a pregnancy in the preceding
three months. Table 10 presents the proportion of women who reported experiencing a pregnancy at some
point during the study, among all women who were interviewed in at least one follow-up interview (n=2,559).
These proportions are not contraceptive failure rates, as some women had stopped using their contraceptive
method prior to experiencing pregnancy. Overall, 7 percent reported experiencing a pregnancy during the
study. Ten percent of OCP users, 8 percent of injectable users, 5 percent of interval IUD users, and 2 percent
of PPIUD users at enrollment experienced a pregnancy.
TABLE 10. EXPERIEN CE OF PREGNANCY DURING THE 12-MONTH STUDY PERIOD,
BY ENROLLMENT METHOD
Experienced a pregnancy at some point during the study
Enrollment method*
PPIUD (n=376)
Interval IUD (n=620)
Injectable (n=531)
OCP (n=1,032)
Combined (n=2,559)

* p<0.05

%

n

2.4
5.6
7.7
9.5
7.2

9
35
41
98
183

Clients who experienced a pregnancy during the study period (n=183) were also asked about the intendedness
of that pregnancy: whether the pregnancy was wanted then, wanted later, or not wanted at all (Table 11).
Intendedness of the pregnancy was asked of women when the pregnancy was first reported. Slightly less than
half (49%) of women who experienced a pregnancy wanted their pregnancy at the time they became
pregnant, while 24 percent wanted to become pregnant at a later time. Just over one-quarter (27%) did not
want to become pregnant at all, and one percent didn’t know.
TABLE 11. INTENDED NESS OF PREGNANCY WHEN FIRST R EPORTED, AMONG
WOMEN WHO EXPERI ENCED A PREGNANCY DURING THE STUDY PERIOD, BY
ENROLLMENT METHO D
Intendedness of pregnancy when first reported
Enrollment method
PPIUD (n=9)
IUD (n=35)
Injectable (n=41)
OCP (n=98)
Combined (n=183)

Wanted then

Wanted later

Not wanted at all

Don't know

66.7
60.0
34.1
50.0
49.2

11.1
17.1
19.5
28.6
23.5

22.2
22.9
43.9
20.4
26.2

0.0
0.0
2.4
1.0
1.1

Of those who reported wanting their pregnancy at the time they became pregnant, 64 percent reported that
they had discontinued their enrollment method due to a desire to become pregnant, while others
discontinued due to side effects (11%), lack of menstruation (6%), inconvenience (2%), husband not living at
home (2%), husband opposition (1%), mother-in-law opposition (1%), or did not list a reason (18%)
(multiple responses possible, data not shown). On the other hand, 23 percent of those who wanted their
pregnancy later and 17 percent of those who did not want their pregnancy at all reported discontinuing their
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enrollment method due to method failure. However, 37 percent of those who reported they wanted their
pregnancy at a later time also reported that they discontinued because they wanted to become pregnant, while
this was a reason for only 7 percent of those who reported they did not want to become pregnant at all. Side
effects/health concerns was a reason for discontinuation listed by 10 percent of those who wanted to become
pregnant later and 24 percent of those who did not want to become pregnant at all, suggesting that these
women would have been potential candidates for method switching.
Women who reported experiencing a pregnancy during the study also reported whether that pregnancy ended
in termination or miscarriage. Of the 183 pregnancies reported during the study period, six ended in
miscarriage and 25 ended in termination. Eight women used a pill to terminate the pregnancy, while 17
reported termination by a cleaning done by a doctor or nurse (data not shown).

Strengths and limitations of the study
This study has collected longitudinal data on modern reversible contraceptive users in India, a largely
understudied group, but a group that is a focus of India’s FP2020 commitment. One of the most significant
strengths of this study was that it was conducted prospectively, so that the effect of recall bias on responses
was reduced considerably compared to retrospective studies.
One limitation of the study is that timing and strategies for enrollment into the study varied by state and
family planning method. Women in Haryana were enrolled into the study via ASHAs and enrollment began
several months after it began in Odisha, where enrollment occurred at government facilities, at NGO
facilities, and through ASHAs.
Additionally, enrollment of injectable users was challenging, and the desired sample size was not met, as the
study began just before the method was rolled out in the public sector. However, these findings can be useful
for the Government of India in planning how to allocate future resources for injectable use.
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Discussion
The purpose of this longitudinal study was to assess the dynamics of reversible contraceptive use over the
course of one year, including contraceptive choice, discontinuation, and switching behaviors, as well as quality
of care and experience of side effects. A total of 2,699 married women of reproductive age (15-49 years) from
Odisha and Haryana states were enrolled into the study, including 420 PPIUD users, 640 interval IUD users,
581 injectable users, and 1,066 OCP users. As respondents were purposively sampled, estimates are not
representative of contraceptive users at the state level nor of all method-specific users. However, these data
can provide valuable insights for understanding the experiences of reversible contraceptive users, which is
critical in India as the government aims to expand access to and use of reversible contraceptives in its
national family planning program.
In the enrollment interview, women were asked about the quality of care they received from the provider or
frontline health worker who provided them with or counseled them about their method. While there were
some aspects of quality of care that the majority of women across all methods received, such as being treated
well (99-100%) or being told how the chosen method works (ranging from 66 percent of PPIUD users to 91
percent of OCP users), there is room for improvement in quality, because 100 percent of women should be
reporting receiving quality of care across the four domains: respectful care, method selection, effective use of
method selected, and continuity of contraceptive use and care. Though this study did not observe clientprovider interactions, clients’ reported quality received provides insights into what information they were
walking away with after interacting with providers. Additionally, while responses about process quality
received may be subject to recall bias, this is likely to be minimal because the enrollment interview occurred
within 30 days of a woman receiving her family planning method.
There were differences in quality received by method and other respondent characteristics. For instance,
PPIUD users consistently reported receiving lower levels of quality of care compared to users of other
methods. PPIUD users may have received counseling and information from providers or frontline health
workers during antenatal care visits, but the information exchange between provider and client should be
reiterated at the time of insertion, even if counseling had occurred prior. Additionally, the differences in
receipt of the MIIplus by wealth tertile and urban/rural residence suggest that there is a need to ensure that
all women receive high quality care, regardless of their financial means and where they live.
Implications: Quality of care should be improved for users of all modern methods of family
planning, and especially for PPIUD users and women of lower wealth status. Quality of care
improvement efforts should also be routinely monitored and tracked to ensure that women are
receiving high quality services. Providers of all cadres should be trained on respectful care, and
information exchange on appropriate method selection, effective use of methods, and continuity
of contraceptive use and care.
At each follow-up interview, women were asked whether they had experienced side effects of their family
planning method. Just 23 percent of women had experienced at least one side effect while using their
enrollment method throughout the course of the study, though this varied widely by method. Half of
injectable users (50%) experienced a side effect while using the method, while this was true for 22 percent of
PPIUD users, 22 percent of IUD users, and 11 percent of OCP users. The most common side effects were
heavy bleeding (reported by 6% of women), abdominal pain (6%), and lack of menstruation (6%). Less than
one in five women (18%) talked to someone about side effects, and only 12 percent spoke to a provider or
health worker about the side effects, suggesting women who have recently begun using a contraceptive
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method are not always seeking follow-up care or being visited by frontline health workers. Injectable users
were the most likely to experience side effects, and also the most likely to discontinue their method over the
course of the study. As the injectable is a relatively new method available in public health facilities in India,
understanding that half of injectable users experienced side effects and most discontinued the method is
valuable information for the Indian government to use in efforts to make the method more widely available
across the country. Before starting the method, women who receive the injectable should be adequately
counseled on side effects of the method, what to do if they experience side effects, and what methods they
could switch to if the side effects of the injectable make it an unsuitable method.
Women’s reasons for discontinuation of the enrollment method shed additional light on their contraceptive
use dynamics. Among women who discontinued the enrollment method at some point during the study
(n=921), reasons for discontinuation were primarily related to the method used: the most commonly cited
reason was side effects/health concerns (24%). Twenty percent discontinued due to not menstruating since
starting the method, and this was the most common reason among injectable users. Given this large
proportion of discontinuation due to side effects and changes in menstruation, it is critical that providers
discuss potential side effects of available methods, how they might impact women’s lives, and any other
health concerns a woman has before she adopts a method. Modern fertility-awareness based methods may be
a suitable alternative for women who want to prevent pregnancy but find these side effects unacceptable, and
should be included in counseling on method selection. Other women discontinued for fertility-related
reasons: 12 percent of discontinuers wanted to become pregnant and 10 percent reported their husband was
not living at home, and these proportions were greater among OCP users. These women did not have an
immediate need for family planning and discontinued their method according to their fertility preferences and
needs.
Implications: Most women (77%) did not report experiencing side effects on their enrollment
method, though many who discontinued the enrollment method did so due to side effects or other
health concerns. Contraceptive initiators should receive follow-up visits from frontline health
workers to provide support and answer questions related to the method selected. These visits
could assist women with information on managing side effects or switching to a different method.
While most women—61 percent—continued to use the method they adopted at enrollment throughout the
year, considerable movement among contraceptive use states was observed, including switching to different
FP methods, continuing use of the switched methods, or discontinuing contraceptive use altogether. These
findings highlight the importance of providers and ASHAs offering continuous support to women who want
to delay or prevent pregnancy that includes opportunities to switch methods as their fertility desires change
over time. Information and FP methods offered to women at the initial FP visit alone is not enough to ensure
that women continuously meet their needs for voluntary contraceptive use; continuous follow-up is needed.
Interval IUD (74%) and OCP (75%) users were most likely to continue to use these methods they began at
enrollment, followed by PPIUD users (66%). Less than half (44%) of injectable users continued to use
injectables. While many of those who initiated the injectable at enrollment went on to switch to a different
modern method by 12 months (23%), one-third (33%) discontinued modern contraception altogether.
Compared to other methods, injectable users tended to be older in age, had more living children, were more
likely to have used a modern method previously, and were more likely to want to stop childbearing all
together at enrollment. Sixty-eight percent of those who initiated injectables at enrollment, but discontinued
contraception altogether did not want to have any more children at 12 months, suggesting that these
injectable discontinuers are potential good candidates for receiving information and support to switch to a
different modern method.
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The importance of ensuring women are provided with information about contraceptive switching is
underlined by the high level of unmet need among women who discontinued using contraception after one
year. Overall, discontinuation of all contraception was low, at 13 percent. However, less than one-third of
those not using any method after one year wanted to get pregnant in the next two years (31%). Half of those
not using any method did not want to have any more children in the future, 7 percent wanted to wait more
than two years, and 12 percent didn’t know. These women, a total of 69 percent of non-users, therefore had
an unmet need for contraception at the end of one year and may benefit from information and support to
enable switching to a different modern method of contraception.
Implications: Discontinuation of contraceptive use altogether after one year was relatively low.
There was considerable movement between various states of contraceptive use. Women did
switch to other methods, both modern as well as traditional methods. Among those who were not
using at 12 months, however, the majority had an unmet need for family planning. At the time of
method adoption and after the initial visit, it is important to continue to offer women information
about the possibility of switching to other methods, including modern fertility awareness-based
methods.
At enrollment, most women wanted to use their family planning method for limiting (59%) or delaying
childbearing for at least two years (28%). While these preferences appeared to be relatively stable over time,
there were substantial variations in fertility preferences over the course of the study at the individual level. For
example, when examining the data longitudinally, over one-third (35%) of women who did not want to have
any children at enrollment changed their mind and reported wanting to have more children in at least one
follow-up interview. This was even higher for women who reported wanting a child within two years (86%
changed their mind), in more than two years (95% changed their mind), or didn’t know (87% changed their
mind). Additionally, a significant proportion didn’t know whether or when they wanted to have another child
in at least one interview, as 6 percent of respondents at enrollment and 15 percent after one year were unsure.
Being unsure of fertility preferences is a legitimate response that may change over time, and providers and
ASHAs should be sure to ask women about their fertility preferences at each interaction.
When asking women about their fertility desires, a better understanding of their motivations to prevent
pregnancy and under what circumstances they may change their mind may help providers support women in
selecting appropriate methods. Particularly in India, where 75 percent of family planning users use female
sterilization, a deeper understanding of fertility desires and motivations may help to prevent sterilization
regret, which has been reported by seven percent of women who have undergone the procedure (Singh
2018).
Implications: These data show that while fertility intentions appear to remain relatively
consistent over a year, women’s desires can and do change. Asking women about their fertility
intentions and motivation to prevent pregnancy routinely in FP counseling can help ensure that
women are selecting methods that best meet their changing reproductive needs.
After one year, 62 percent of respondents did not want to have any more children. While those using modern
methods after one year were most likely to report not wanting to have any more children (64%), over half of
those using traditional methods (56%) and half of those not using any method (50%) did not want any more
children either. Women using traditional methods or not using family planning at all would be potential
candidates for modern methods of contraception, including modern fertility awareness-based methods, and
should be supported in switching to a different modern method if that would better meet their contraceptive
needs. Since such a large proportion of modern, traditional, and non-users of family planning desired no
more children, and since this was the strongest fertility preference among this sample of women, there is a
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rationale to continue supporting the female sterilization program in India. Coupled with counseling about
fertility preferences and motivation to prevent pregnancy, this could help enable women in India with an
unmet need for limiting to meet their reproductive intentions.
Implications: India should continue to expand the basket of methods available to women while
supporting sterilization as part of the national family planning program.
Seven percent of women, including both those who were using and not using a method at the time of followup, experienced a pregnancy at some point during the study. (This study did not calculate failure rates of
contraceptive methods.) Of the 183 women who experienced a pregnancy during the study period, half (51%)
did not want to become pregnant at all, did not want to become pregnant at that time, or didn’t know. This
underscores the importance of enabling women to continue using modern contraception that fits their
reproductive needs. Less than 10 percent of women who experienced a pregnancy terminated the pregnancy.
Implications: As half of pregnancies experienced in this study were not wanted at all or at that
time, there is a need to ensure that women are offered an array of methods to switch to in order to
prevent unwanted pregnancies.
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